J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silber, H. E.
Right arrow Articles by Karlsson, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silber, H. E.
Right arrow Articles by Karlsson, M. O.

QUANTITATIVE CLINICAL PHARMACOLOGY

An Integrated Model for Glucose and Insulin Regulation in Healthy Volunteers and Type 2 Diabetic Patients Following Intravenous Glucose Provocations

Hanna E. Silber, MSc Pharm, Petra M. Jauslin, MSc Pharm, Nicolas Frey, PharmD, Ronald Gieschke, MD, Ulrika S. H. Simonsson, PhD and Mats O. Karlsson, PhD

From the Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, University of Uppsala, Sweden (Ms Silber, Ms Jauslin, Dr Simonsson, Dr Karlsson); and Clinical Pharmacology, Modeling and Simulation Group, F. Hoffmann-La Roche Inc, Basel, Switzerland (Ms Jauslin, Dr Frey, Dr Gieschke).

An integrated model for the regulation of glucose and insulin concentrations following intravenous glucose provocations in healthy volunteers and type 2 diabetic patients was developed. Data from 72 individuals were included. Total glucose, labeled glucose, and insulin concentrations were determined. Simultaneous analysis of all data by nonlinear mixed effect modeling was performed in NONMEM. Integrated models for glucose, labeled glucose, and insulin were developed. Control mechanisms for regulation of glucose production, insulin secretion, and glucose uptake were incorporated. Physiologically relevant differences between healthy volunteers and patients were identified in the regulation of glucose production, elimination rate of glucose, and secretion of insulin. The model was able to describe the insulin and glucose profiles well and also showed a good ability to simulate data. The features of the present model are likely to be of interest for analysis of data collected in antidiabetic drug development and for optimization of study design.


Key Words: Glucose homeostasishot glucoseIVGTTNONMEM

Address for correspondence: Hanna E. Silber, Box 591, SE-751 24 Uppsala, Sweden.




This article has been cited by other articles:


Home page
J Clin PharmacolHome page
P. M. Jauslin, H. E. Silber, N. Frey, R. Gieschke, U. S. H. Simonsson, K. Jorga, and M. O. Karlsson
An Integrated Glucose-Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics
J. Clin. Pharmacol., October 1, 2007; 47(10): 1244 - 1255.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Clinical Pharmacology